A retrospective study reported high recent use of GLP-1 receptor agonists in people living with HIV at a UK centre, with ...
University of British Columbia news release. The HPV vaccine provides strong, long-lasting protection for women living with ...
CROWN is the first large, phase IIIb trial to evaluate the investigational use of LA Cabenuva versus daily oral therapy in ...
As the population of people with HIV ages, researchers studied cognitive health changes; 46% of study participants were ...
Among women with steatotic liver disease, HIV was associated with 48% greater adjusted odds of clinically significant ...
The virus directly killed an estimated 0.9 million people in 2023, ranking 14th, as global life expectancy climbed back to ...
Women with HIV have almost twice the risk of CVD compared to women without HIV, while men with HIV have a 44% increased risk ...
ECDC released a report assessing the current situation regarding availability and access to prevention, testing, and ...
Mirum Pharmaceuticals press release. Mirum Pharmaceuticals, Inc. announced the primary endpoint was met in the Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results